+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adrenal Hyperplasia Drug"

Congenital Adrenal Hyperplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Congenital Adrenal Hyperplasia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Adrenocorticotropic Hormone Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Adrenocorticotropic Hormone Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 62 Pages
  • Global
From
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Adrenal Hyperplasia Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat adrenal hyperplasia, a condition in which the adrenal glands produce too much of certain hormones. These drugs work by blocking the production of these hormones, allowing the body to regulate its own hormone levels. Common drugs used to treat adrenal hyperplasia include corticosteroids, mineralocorticoids, and androgens. These drugs are typically administered orally or through injections. The Adrenal Hyperplasia Drug market is highly competitive, with many companies offering a variety of drugs to treat the condition. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. These companies are constantly developing new drugs and treatments to improve the quality of life for those suffering from adrenal hyperplasia. Show Less Read more